VOYA Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387M Sell
1,780,456
-679,910
-28% -$151M 0.4% 55
2025
Q4
$562M Buy
2,460,366
+4,986
+0.2% +$1.14M 0.55% 27
2025
Q3
$568M Buy
2,455,380
+449,794
+22% +$91.6M 0.57% 28
2025
Q2
$372M Sell
2,005,586
-595,134
-23% -$111M 0.37% 46
2025
Q1
$545M Buy
2,600,720
+499,808
+24% +$97.2M 0.61% 22
2024
Q4
$373M Sell
2,100,912
-336,891
-14% -$61.9M 0.39% 40
2024
Q3
$481M Buy
2,437,803
+669,732
+38% +$125M 0.5% 26
2024
Q2
$303M Sell
1,768,071
-138,703
-7% -$23M 0.3% 67
2024
Q1
$347M Buy
1,906,774
+224,659
+13% +$38.7M 0.34% 63
2023
Q4
$260M Buy
1,682,115
+817,153
+94% +$119M 0.27% 79
2023
Q3
$129M Sell
864,962
-1,620,134
-65% -$238M 0.14% 178
2023
Q2
$335M Sell
2,485,096
-34,178
-1% -$5.01M 0.35% 64
2023
Q1
$401M Sell
2,519,274
-1,554,834
-38% -$238M 0.43% 39
2022
Q4
$658M Buy
4,074,108
+1,031,943
+34% +$158M 0.76% 13
2022
Q3
$408M Buy
3,042,165
+2,162,234
+246% +$310M 0.49% 34
2022
Q2
$135M Sell
879,931
-16,841
-2% -$2.57M 0.34% 70
2022
Q1
$145M Sell
896,772
-51,621
-5% -$7.5M 0.3% 76
2021
Q4
$128M Buy
948,393
+43,201
+5% +$5.1M 0.25% 94
2021
Q3
$97.6M Sell
905,192
-23,754
-3% -$2.71M 0.2% 116
2021
Q2
$105M Sell
928,946
-76,589
-8% -$8.63M 0.2% 112
2021
Q1
$109M Sell
1,005,535
-26,935
-3% -$2.88M 0.22% 103
2020
Q4
$111M Sell
1,032,470
-3,536,003
-77% -$340M 0.22% 108
2020
Q3
$400M Buy
4,568,473
+44,945
+1% +$4.23M 0.89% 9
2020
Q2
$444M Buy
4,523,528
+752,943
+20% +$66.3M 1.03% 8
2020
Q1
$287M Buy
3,770,585
+524,524
+16% +$44.7M 0.77% 18
2019
Q4
$287M Buy
3,246,061
+2,133,475
+192% +$177M 0.59% 38
2019
Q3
$84.2M Buy
1,112,586
+7,598
+0.7% +$521K 0.18% 125
2019
Q2
$80.4M Buy
1,104,988
+159,858
+17% +$12.6M 0.17% 131
2019
Q1
$76.2M Sell
945,130
-3,575
-0.4% -$292K 0.17% 131
2018
Q4
$87.5M Buy
948,705
+79,374
+9% +$6.98M 0.22% 111
2018
Q3
$82.2M Buy
869,331
+49,271
+6% +$4.67M 0.17% 133
2018
Q2
$76M Buy
820,060
+14,708
+2% +$1.44M 0.16% 141
2018
Q1
$76.2M Sell
805,352
-499,849
-38% -$54.9M 0.16% 142
2017
Q4
$126M Buy
1,305,201
+534,248
+69% +$50.4M 0.26% 94
2017
Q3
$68.5M Sell
770,953
-149,142
-16% -$11.4M 0.15% 149
2017
Q2
$66.7M Sell
920,095
-32,181
-3% -$2.16M 0.15% 153
2017
Q1
$62.1M Sell
952,276
-50,315
-5% -$3.16M 0.14% 150
2016
Q4
$62.8M Sell
1,002,591
-1,902,392
-65% -$116M 0.15% 147
2016
Q3
$183K Sell
2,904,983
-27,253
-0.9% -$1.76M 0.35% 53
2016
Q2
$182M Sell
2,932,236
-3,223,017
-52% -$196M 0.45% 53
2016
Q1
$352M Buy
6,155,253
+5,325,857
+642% +$297M 0.87% 14
2015
Q4
$49.1M Sell
829,396
-27,310
-3% -$1.57M 0.12% 174
2015
Q3
$46.6M Sell
856,706
-1,490
-0.2% -$97K 0.12% 176
2015
Q2
$57.7M Sell
858,196
-13,681
-2% -$893K 0.13% 163
2015
Q1
$51M Sell
871,877
-4,580,772
-84% -$277M 0.11% 181
2014
Q4
$357M Sell
5,452,649
-131,643
-2% -$8.3M 0.79% 16
2014
Q3
$323M Buy
5,584,292
+2,632,170
+89% +$146M 0.73% 19
2014
Q2
$167M Buy
2,952,122
+2,128,656
+258% +$112M 0.38% 67
2014
Q1
$42.3M Buy
823,466
+11,685
+1% +$591K 0.1% 199
2013
Q4
$42.9M Buy
811,781
+40,445
+5% +$1.99M 0.1% 190
2013
Q3
$34.5M Sell
771,336
-134,818
-15% -$5.98M 0.09% 225
2013
Q2
$37.5M Buy
+906,154
New +$39.6M 0.1% 186

Other funds holding ABBV

VOYA Investment Management's ABBV Position: Q1 2026 in Review

VOYA Investment Management reduced its AbbVie (ABBV) stake by 28% in Q1 2026, selling an estimated $151M and leaving 1,780,456 shares worth $387M. The position accounts for 0.4% of the portfolio, ranked #55.

VOYA Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $658M in Q4 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • VOYA Investment Management held 1,780,456 shares of AbbVie worth $387M as of Q1 2026.
  • VOYA Investment Management sold 679,910 AbbVie shares in Q1 2026, an estimated $151M.
  • AbbVie made up 0.4% of VOYA Investment Management's portfolio in Q1 2026, its #55 holding.
  • VOYA Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's AbbVie position peaked at $658M in Q4 2022.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.